Escitalopram Research Overview
Lexaheal 10 mg by Healing Pharma is a selective serotonin reuptake inhibitor (SSRI) formulation containing escitalopram, an S-enantiomer of citalopram. This research compound enables detailed investigation of serotonin transporter (SERT) inhibition mechanisms and monoaminergic neurotransmission pathways. Researchers at Stroid UK Shop utilise escitalopram formulations to examine selective serotonin reuptake blocking activity, examining its high selectivity for the serotonin transporter compared to norepinephrine and dopamine transporters. The compound demonstrates potent inhibitory activity with minimal off-target effects in preclinical models, making it valuable for studying depression-related neurobiology and anxiolytic mechanisms.
Laboratory Research Applications
Escitalopram serves as a critical research tool for investigating SSRI pharmacology and serotonin pathway modulation. Scientists examine its binding affinity to the serotonin transporter, analysing competitive inhibition kinetics and receptor selectivity profiles. Research applications include studying synaptic serotonin concentration effects, examining downstream signalling cascades, and investigating neuroplasticity mechanisms. The compound enables researchers to evaluate serotonin transporter occupancy rates, examine dose-response relationships, and analyse metabolic pathways involving CYP2C19 and CYP3A4 enzyme systems. Comparative studies utilise escitalopram alongside compounds from our escitalopram research collection to investigate SSRI class differences and receptor binding specificities.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Escitalopram |
| Formulation Strength | 10 mg per unit |
| Manufacturer | Healing Pharma |
| Chemical Class | Selective Serotonin Reuptake Inhibitor |
| CAS Number | 128196-01-0 |
| Molecular Formula | C₂₀H₂₁FN₂O |
| Molecular Weight | 324.39 g/mol |
| Storage Requirements | Room temperature, dry conditions |
Researchers studying neurotransmitter systems often combine escitalopram investigations with compounds from our SARMs research collection and peptide research compounds to examine multi-pathway interactions and comparative pharmacological profiles. The pharmaceutical-grade formulation ensures consistent dosing for reproducible experimental protocols.
Research Compliance Statement
Lexaheal 10 mg Healing Pharma is supplied strictly for in-vitro laboratory research purposes only. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must comply with all applicable regulations regarding SSRI compound handling, storage protocols, and experimental safety procedures when conducting escitalopram-based studies.
